{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:04:31Z","timestamp":1781049871014,"version":"3.54.1"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T00:00:00Z","timestamp":1781049600000},"content-version":"vor","delay-in-days":53,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Landspitali Science Fund"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-49262-z","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T03:19:22Z","timestamp":1776482362000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["The incidence and clinical variables associated with new and new persistent benzodiazepine use after admission to internal medicine: a retrospective study"],"prefix":"10.1038","volume":"16","author":[{"given":"Eyglo Soley Hrodmarsd\u00f3ttir","family":"Love","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freyja","family":"Jonsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Ingi","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"2","key":"49262_CR1","first-page":"214","volume":"13","author":"CE Griffin","year":"2013","unstructured":"Griffin, C. E. et al. Benzodiazepine pharmacology and central nervous system-mediated effects. Ochsner J. 13 (2), 214\u2013223 (2013).","journal-title":"Ochsner J."},{"issue":"12","key":"49262_CR2","doi-asserted-by":"publisher","first-page":"1096","DOI":"10.1177\/0004867414548902","volume":"48","author":"B Albrecht","year":"2014","unstructured":"Albrecht, B. et al. Benzodiazepine use and aggressive behaviour: A systematic review. Aust N Z. J. Psychiatry. 48 (12), 1096\u20131114. https:\/\/doi.org\/10.1177\/0004867414548902 (2014).","journal-title":"Aust N Z. J. Psychiatry"},{"key":"49262_CR3","doi-asserted-by":"publisher","unstructured":"Hsu, T. W. et al. The Association between use of benzodiazepine receptor agonists and the risk of obstructive sleep apnea: A Nationwide population-based nested case-control study. Int. J. Environ. Res. Public. Health. https:\/\/doi.org\/10.3390\/ijerph18189720 (2021).","DOI":"10.3390\/ijerph18189720"},{"issue":"1","key":"49262_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1111\/bcpt.13811","volume":"132","author":"M H\u00f8jlund","year":"2023","unstructured":"H\u00f8jlund, M. et al. Use of benzodiazepines and benzodiazepine-related drugs in the Nordic countries between 2000 and 2020. Basic Clin. Pharmacol. Toxicol. 132 (1), 60\u201370. https:\/\/doi.org\/10.1111\/bcpt.13811 (2023).","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"49262_CR5","unstructured":"U.S. Food and Drug Administration. Benzodiazepine drug information. (U.S. Food and Drug Administration, accessed 06 April 2024); [updated 09\/23\/2020; cited 2024 06\/04\/2024]. Available from: https:\/\/www.fda.gov\/drugs\/information-drug-class\/benzodiazepine-drug-information."},{"key":"49262_CR6","doi-asserted-by":"publisher","unstructured":"Guina, J. & Merrill, B. Benzodiazepines I. Upping the care on downers: The evidence of risks, benefits and alternatives. J. Clin. Med. https:\/\/doi.org\/10.3390\/jcm7020017 (2018).","DOI":"10.3390\/jcm7020017"},{"issue":"11","key":"49262_CR7","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1177\/0269881113503509","volume":"27","author":"DS Baldwin","year":"2013","unstructured":"Baldwin, D. S. et al. Benzodiazepines: Risks and benefits. A reconsideration. J. Psychopharmacol. 27 (11), 967\u2013971. https:\/\/doi.org\/10.1177\/0269881113503509 (2013).","journal-title":"J. Psychopharmacol."},{"issue":"4","key":"49262_CR8","doi-asserted-by":"publisher","first-page":"594","DOI":"10.3390\/neurolint13040059","volume":"13","author":"AN Edinoff","year":"2021","unstructured":"Edinoff, A. N. et al. Benzodiazepines: Uses, dangers, and clinical considerations. Neurol. Int. 13 (4), 594\u2013607. https:\/\/doi.org\/10.3390\/neurolint13040059 (2021).","journal-title":"Neurol. Int."},{"key":"49262_CR9","doi-asserted-by":"publisher","unstructured":"Sanabria, E. et al. Benzodiazepines: Their use either as essential medicines or as toxics substances. Toxics. https:\/\/doi.org\/10.3390\/toxics9020025 (2021).","DOI":"10.3390\/toxics9020025"},{"issue":"5","key":"49262_CR10","doi-asserted-by":"publisher","first-page":"1205","DOI":"10.1016\/j.surg.2022.12.024","volume":"173","author":"\u00de Albertsson","year":"2023","unstructured":"Albertsson, \u00de. et al. The incidence of new and persistent benzodiazepine use after surgery. Surgery 173 (5), 1205\u20131212. https:\/\/doi.org\/10.1016\/j.surg.2022.12.024 (2023).","journal-title":"Surgery"},{"issue":"3","key":"49262_CR11","doi-asserted-by":"publisher","first-page":"e078890","DOI":"10.1136\/bmjopen-2023-078890","volume":"14","author":"F Jonsdottir","year":"2024","unstructured":"Jonsdottir, F. et al. The association of degree of polypharmacy before and after among hospitalised internal medicine patients and clinical outcomes: A retrospective, population-based cohort study. BMJ Open. 14 (3), e078890. https:\/\/doi.org\/10.1136\/bmjopen-2023-078890 (2024).","journal-title":"BMJ Open."},{"issue":"6","key":"49262_CR12","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1097\/MLR.0b013e31819432e5","volume":"47","author":"C van Walraven","year":"2009","unstructured":"van Walraven, C. et al. A modification of the elixhauser comorbidity measures into a point system for hospital death using administrative data. Med. Care. 47 (6), 626\u2013633. https:\/\/doi.org\/10.1097\/MLR.0b013e31819432e5 (2009).","journal-title":"Med. Care"},{"issue":"1","key":"49262_CR13","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/00005650-199801000-00004","volume":"36","author":"A Elixhauser","year":"1998","unstructured":"Elixhauser, A. et al. Comorbidity measures for use with administrative data. Med. Care. 36 (1), 8\u201327 (1998).","journal-title":"Med. Care"},{"issue":"10132","key":"49262_CR14","doi-asserted-by":"publisher","first-page":"1775","DOI":"10.1016\/s0140-6736(18)30668-8","volume":"391","author":"T Gilbert","year":"2018","unstructured":"Gilbert, T. et al. Development and validation of a hospital frailty risk score focusing on older people in acute care settings using electronic hospital records: An observational study. Lancet 391 (10132), 1775\u20131782. https:\/\/doi.org\/10.1016\/s0140-6736(18)30668-8 (2018).","journal-title":"Lancet"},{"key":"49262_CR15","unstructured":"R. A language and environment for statistical computing [program]. 4.3.2 version (R Foundation for Statistical Computing, 2023)."},{"key":"49262_CR16","unstructured":"RStudio. Integrated development for R [program]. 2023.12.0.369 version (RStudio, PBC, 2023)."},{"key":"49262_CR17","doi-asserted-by":"publisher","unstructured":"J\u00f3nsd\u00f3ttir, F. et al. Epidemiology and association with outcomes of polypharmacy in patients undergoing surgery: Retrospective, population-based cohort study. BJS Open. https:\/\/doi.org\/10.1093\/bjsopen\/zrad041 (2023).","DOI":"10.1093\/bjsopen\/zrad041"},{"issue":"4","key":"49262_CR18","doi-asserted-by":"publisher","first-page":"2670","DOI":"10.1016\/j.sapharm.2021.06.001","volume":"18","author":"S Coll","year":"2022","unstructured":"Coll, S. et al. Hospital initiation of benzodiazepines and Z-drugs in older adults and discontinuation in primary care. Res. Soc. Adm. Pharm. 18 (4), 2670\u20132674. https:\/\/doi.org\/10.1016\/j.sapharm.2021.06.001 (2022).","journal-title":"Res. Soc. Adm. Pharm."},{"issue":"12","key":"49262_CR19","doi-asserted-by":"publisher","first-page":"e70056","DOI":"10.1002\/pds.70056","volume":"33","author":"ET Mansi","year":"2024","unstructured":"Mansi, E. T. et al. Patient characteristics and practice variation associated with new community prescription of benzodiazepine and z-drug hypnotics after critical illness: A retrospective cohort study using the UK clinical practice research datalink. Pharmacoepidemiol Drug Saf. 33 (12), e70056. https:\/\/doi.org\/10.1002\/pds.70056 (2024).","journal-title":"Pharmacoepidemiol Drug Saf."},{"key":"49262_CR20","unstructured":"Editorial group for NOMESCO health statistics. Use of addictive medicine: Nordic Health & Welfare Statistics (accessed 08 April 2024); 2019 [updated 17\/01\/2024; cited 2024 17\/06\/2025]. Available from: https:\/\/nhwstat.org\/health\/thematic-articles-health\/use-addictive-medicine (2025)."},{"issue":"1","key":"49262_CR21","doi-asserted-by":"publisher","first-page":"e187399","DOI":"10.1001\/jamanetworkopen.2018.7399","volume":"2","author":"SD Agarwal","year":"2019","unstructured":"Agarwal, S. D. & Landon, B. E. Patterns in outpatient benzodiazepine prescribing in the United States. JAMA Netw. Open. 2 (1), e187399. https:\/\/doi.org\/10.1001\/jamanetworkopen.2018.7399 (2019).","journal-title":"JAMA Netw. Open."},{"issue":"8","key":"49262_CR22","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1016\/j.jpsychires.2011.03.006","volume":"45","author":"CP McLean","year":"2011","unstructured":"McLean, C. P. et al. Gender differences in anxiety disorders: Prevalence, course of illness, comorbidity and burden of illness. J. Psychiatr Res. 45 (8), 1027\u20131035. https:\/\/doi.org\/10.1016\/j.jpsychires.2011.03.006 (2011).","journal-title":"J. Psychiatr Res."},{"issue":"2","key":"49262_CR23","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1111\/j.1365-2125.2008.03185.x","volume":"66","author":"CS van der Hooft","year":"2008","unstructured":"van der Hooft, C. S. et al. Inappropriate benzodiazepine use in older adults and the risk of fracture. Br. J. Clin. Pharmacol. 66 (2), 276\u2013282. https:\/\/doi.org\/10.1111\/j.1365-2125.2008.03185.x (2008).","journal-title":"Br. J. Clin. Pharmacol."},{"issue":"4","key":"49262_CR24","doi-asserted-by":"publisher","first-page":"e0174730","DOI":"10.1371\/journal.pone.0174730","volume":"12","author":"K Donnelly","year":"2017","unstructured":"Donnelly, K. et al. Benzodiazepines, Z-drugs and the risk of hip fracture: A systematic review and meta-analysis. PLoS One. 12 (4), e0174730. https:\/\/doi.org\/10.1371\/journal.pone.0174730 (2017).","journal-title":"PLoS One"},{"issue":"9","key":"49262_CR25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1007\/s11606-016-3740-0","volume":"31","author":"DS Kroll","year":"2016","unstructured":"Kroll, D. S. et al. Benzodiazepines are prescribed more frequently to patients already at risk for benzodiazepine-related adverse events in primary care. J. Gen. Intern. Med. 31 (9), 1027\u20131034. https:\/\/doi.org\/10.1007\/s11606-016-3740-0 (2016).","journal-title":"J. Gen. Intern. Med."},{"issue":"10","key":"49262_CR26","doi-asserted-by":"publisher","first-page":"Cd007354","DOI":"10.1002\/14651858.CD007354.pub3","volume":"10","author":"ST Simon","year":"2016","unstructured":"Simon, S. T. et al. Benzodiazepines for the relief of breathlessness in advanced malignant and non-malignant diseases in adults. Cochrane Database Syst. Rev. 10 (10), Cd007354. https:\/\/doi.org\/10.1002\/14651858.CD007354.pub3 (2016).","journal-title":"Cochrane Database Syst. Rev."},{"issue":"2","key":"49262_CR27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1183\/09031936.00008014","volume":"44","author":"NT Vozoris","year":"2014","unstructured":"Vozoris, N. T. et al. Benzodiazepine drug use and adverse respiratory outcomes among older adults with COPD. Eur. Respir J. 44 (2), 332\u2013340. https:\/\/doi.org\/10.1183\/09031936.00008014 (2014).","journal-title":"Eur. Respir J."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49262-z","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49262-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:56:26Z","timestamp":1781049386000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-49262-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":27,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["49262"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-49262-z","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"21 November 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval was obtained from the National Bioethics Committee of Iceland (VSN- 21\u2013179), the Data Protection Authority of Iceland, that waived individual consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}}],"article-number":"17968"}}